Hong Kong-listed innovative drug stocks rebounded strongly, with CanSino Biologics (06185.HK) rising over 10%, XtalPi (02228.HK) rising over 4%, and WuXi AppTec (02359.HK) and Innovent Biologics (01801.HK) following suit.
2026-09-22
Hong Kong-listed innovative drug stocks rebounded strongly, with CanSino Biologics (06185.HK) rising over 10%, XtalPi (02228.HK) rising over 4%, and WuXi AppTec (02359.HK) and Innovent Biologics (01801.HK) following suit.